← Back to All Stocks

Sonnet BioTherapeutics Holdings, Inc. (SONN) Analysis

Generated on: 2025-06-22 14:49:21 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 3,133,076 shares

Analysis Values

Current Price
$1.14
Predicted Price
$1.49
Expected Return
15.72%
Confidence Score
0.79
RSI (14)
53.57
MACD
-0.02
Volume
28,900
Float Shares
3,133,076
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249

SONN

Sonnet BioTherapeutics Holdings, Inc.
15.72%
Price: $1.14
Confidence: 0.79
News
Last updated: 2025-06-22 14:49:20

Technical Analysis

RSI: 53.57
MACD: -0.02
Technical Analysis Graph

Risk Analysis

Volatility
90.45%
Max Drawdown
-86.54%
Beta
1.0
Risk Score
90.8

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
TipRanks - 2024-10-10 13:17
Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with Alkem Laboratories Limited to advance the development and commercialization of SON-080, a treatment for diabetic peripheral neuropathy (DPN) in India. This collaboration includes an upfront payment of $1 million to Sonnet, with the potential for an additional $1 million based on developmental milestones. Moreover, Sonnet will receive royalties from the net sales of the produc

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.